- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06392542
Online Intervention for Transgender/Nonbinary Young Adults' Experiences With Alcohol and Romantic Relationships
Developing an Online Intervention Addressing Transgender/Nonbinary Young Adults' Experiences With Alcohol and Romantic Relationships
The objective of this study is to learn more about Whole Selves, an interactive online resource ("intervention") to help transgender and/or nonbinary young adults reflect on their experiences and goals related to both alcohol use and romantic relationships. Existing online interventions focused on alcohol use often aren't a good fit for trans/nonbinary people, and existing relationship education programs don't account for how being trans/nonbinary might influence someone's relationships. For these reasons, the investigator is working with trans/nonbinary young adults and other community stakeholders to create a new intervention specifically for trans/nonbinary young adults. The goals of this clinical trial are to:
- Find out what transgender/nonbinary young adults think of the Whole Selves intervention in order to improve it
- See whether the Whole Selves intervention seems to work as expected
- Help the investigator make plans for a bigger clinical trial of the Whole Selves intervention, which could tell us how well it works
In this study, participants will use the Whole Selves intervention; complete online surveys about themselves, their romantic relationship experiences, their mental health, their alcohol use; and provide feedback on the Whole Selves intervention.
Study Overview
Status
Intervention / Treatment
Detailed Description
This study is a single-arm feasibility study of Whole Selves, an interactive online resource, or intervention, to help transgender/nonbinary young adults reflect on their goals and priorities for their alcohol use and their romantic relationships. Unlike existing alcohol interventions and relationship education programs, Whole Selves is being created in partnership with transgender/nonbinary young adults, and it considers ways that being transgender/nonbinary might affect someone's alcohol use or their romantic relationship experiences. Whole Selves will be based on principles of motivational interviewing, a way of helping people think about changes they might make in certain areas of life (such as their alcohol use). Whole Selves will include stories and videos of transgender/nonbinary people sharing their own experiences with alcohol use and romantic relationships. It will also include interactive activities, such as giving users feedback on how their alcohol use compares to averages for transgender/nonbinary young adults.
In this study, the investigators will ask 107 romantically partnered transgender/nonbinary young adults to use the Whole Selves intervention, and they will collect survey data from participants before and after the intervention. They will use this data to improve the intervention, see whether it seems to work in the ways the investigators expected, and make plans for a future randomized trial that could show whether the intervention is effective in reducing alcohol use, depression, and anxiety.
Participants in this feasibility study will take part remotely, using their own computer or mobile device. They will first have a phone call with someone from the research team to learn more about the study. They will then complete an initial survey about their background, romantic relationship experiences, mental health, and alcohol use. Next, they will use the Whole Selves intervention, which takes about 40 minutes, on their own computer or mobile device. Afterwards, they will fill out a short survey with feedback about Whole Selves. Finally, they will fill out two more surveys about their romantic relationship experiences, mental health, and alcohol use after 30 days and 90 days.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Gabriel R Murchison, PhD MPH
- Phone Number: 617-850-2905
- Email: grmurch@bu.edu
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02118
- Boston University School of Public Health
-
Contact:
- Gabriel R Murchison, PhD MPH
- Phone Number: 617-850-2905
- Email: grmurch@bu.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Self-identify as transgender and/or nonbinary
- Between 18 and 30 years of age, inclusive
- Able to read and write in English
- Residency in the United States
- Currently in a romantic relationship that began at least six weeks prior to enrollment
Exclusion Criteria:
- Prospective participants will be excluded as potentially inauthentic (i.e., not genuinely eligible for the study) based on scoring criteria developed through the investigators' prior online survey research with similar populations.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Whole Selves
Participants assigned to this arm will receive the Whole Selves intervention and complete assessment surveys at baseline, 30 days, and 90 days.
|
Whole Selves is a brief online self-guided intervention addressing transgender/nonbinary young adults' experiences with alcohol use and romantic relationships.
The intervention is delivered in a single session of approximately 40 minutes.
Whole Selves employs principles of technology-adapted motivational interviewing (e.g., eliciting and strengthening participants' internal reasons for behavior change through interactive activities) as well as personalized feedback on participants' self-reported alcohol use and romantic relationship experiences.
The intervention incorporates text and video narratives from transgender/nonbinary people sharing their own experiences with alcohol use and romantic relationships.
Content will be tailored based on participants' current alcohol use and romantic relationship experiences.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Alcoholic drinks per week
Time Frame: Baseline, 30 days, 90 days
|
Average (mean) number of alcoholic drinks per week over the prior 30 days based on timeline followback, i.e., how many alcoholic drinks a participant recalls having on each specific day.
|
Baseline, 30 days, 90 days
|
Depression symptoms
Time Frame: Baseline, 30 days, 90 days
|
Self-report of depression symptoms in the prior 30 days, as measured by the Patient Health Questionnaire-9 (PHQ-9).
The PHQ-9 is a 9-item questionnaire with each item scored from 0 to 3. Scores can range from 0 to 27 (scores of 5-9 are classified as mild depression; 10-14 as moderate depression; 15-19 as moderately severe depression; ≥ 20 as severe depression).
|
Baseline, 30 days, 90 days
|
Anxiety symptoms
Time Frame: Baseline, 30 days, 90 days
|
Self-report of generalized anxiety symptoms in the prior 30 days, as measured by the Generalized Anxiety Disorder-7 (GAD-7).
The GAD-7 is a 7-item instrument with each item scored between 0 and 3 where 0=not at all, and 3= nearly every day.
Scores can range from 0 to 21 and are interpreted as-- scores 0-4: Minimal Anxiety, scores 5-9: Mild Anxiety, scores 10-14: Moderate Anxiety, and scores greater than 15: Severe Anxiety.
|
Baseline, 30 days, 90 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Heavy drinking days
Time Frame: Baseline, 30 days, 90 days
|
The number of days during the past 30 days when a participant recalls having five or more drinks, based on timeline followback, i.e., how many alcoholic drinks a participant recalls having on each specific day.
|
Baseline, 30 days, 90 days
|
Negative alcohol consequences
Time Frame: Baseline, 30 days, 90 days
|
Self-report of negative alcohol consequences based on the Patient-Reported Outcomes Measurement Information System (PROMIS) Alcohol Negative Consequences Short Form.
The PROMIS Alcohol Negative Consequences Short Form is a 7-item instrument with each item scored between 1 and 5 where 1=never and 5=almost always.
These items are summed to calculate a raw score between 0 and 7, which is then converted to a T-score that indicates how much someone experiences negative consequences from their alcohol use relative to the United States general population.
A T-score of 50 indicates that a person reported the same degree of negative alcohol consequences as the average U.S. adult, scores below 50 indicate fewer negative alcohol consequences than the average U.S. adult, and scores above 50 indicate more negative alcohol consequences than the average U.S. adult.
|
Baseline, 30 days, 90 days
|
Intimate Personal Violence (IPV) victimization
Time Frame: Baseline, 30 days, 90 days
|
Measured with the Sexual and Gender Minority adaptation of the Revised Conflict Tactics Scale-Short Form, a 74-item instrument assessing specific forms of aggression (psychological, physical acts, physical injury, and sexual), as well as nonviolent conflict resolution strategies, within romantic partnerships.
Each partner's use of each tactic is assessed separately (perpetration; victimization) Each item is scored from 0=Never to 6=More than 20 times.
The scoring range varies by tactic, with scores of 0 representing the absence of that tactic in the past month, and higher scores indicating a greater frequency of that tactic in the past month.
|
Baseline, 30 days, 90 days
|
Relationship satisfaction
Time Frame: Baseline, 30 days, 90 days
|
Measured with the Couple Satisfaction Index - 4, a four-item instrument assessing overall satisfaction in a romantic relationship.
The response scales vary by item (0=Not at all, 5=Completely for one item; 0=Extremely unhappy, 6=Perfect for two items; and 0=Not at all true, 5=Completely true for one item).
Scores range from 0 to 21, with higher scores indicating higher levels of relationship satisfaction and scores below 13.5 indicating marked dissatisfaction.
|
Baseline, 30 days, 90 days
|
Transgender/nonbinary (TNB) identity support
Time Frame: Baseline, 30 days, 90 days
|
Measured with the Transgender Identity Support from Partners Scale, a 19-item instrument assessing the extent of support a transgender/nonbinary participant's romantic partner provides with respect to the participant's transgender/nonbinary identity.
Response options range from 0=Strongly disagree to 6=Strongly agree.
Scores have a range of 0 to 22.8, with higher scores representing more overall TNB identity support.
|
Baseline, 30 days, 90 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cannabis misuse
Time Frame: Baseline, 30 days, 90 days
|
Measured by the Cannabis Use Disorder Identification Test-Revised (CUDIT-R), an 8-item instrument assessing problematic or harmful cannabis use.
The first 7 items have response options ranging from 0=Never to 4=Daily/almost daily, and the final item has response options ranging from 0=Never to 4=Yes, during the past 6 months.
Scores have a range of 0 to 32, with scores of 8 or more indicating hazardous cannabis use and scores of 12 or more indicating possible cannabis use disorder.
|
Baseline, 30 days, 90 days
|
Past week cannabis use
Time Frame: Baseline, 30 days, 90 days
|
Measured with the question "How many days of the past week did you use cannabis?"
with a definition of cannabis and response options ranging from "1 day" to "7 days."
|
Baseline, 30 days, 90 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Gabriel R Murchison, PhD MPH, Boston University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-44965
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression, Anxiety
-
University Hospital, Strasbourg, FranceCompletedAnxiety Depression DisorderFrance
-
ViomeRecruitingDepression | Anxiety Disorders | Anxiety | Mental Health Disorder | Anxiety Depression | Anxiety State | Mental Health | Depression, Anxiety | Mental Health IssueUnited States
-
3-C Institute for Social DevelopmentUniversity of Miami; Stony Brook UniversityCompletedDepression | Anxiety | Depression, Anxiety | Depression in AdolescenceUnited States
-
University Hospital, Strasbourg, FranceRecruitingDepression Anxiety DisorderFrance
-
UCLH/UCL Joint Research OfficeMedical Research Council; Camden and Islington NHS Trust; Central and North West...RecruitingAnxiety Disorders | Anxiety | Anxiety Depression | CBT | Anxiety Disorders and Symptoms | Anxiety Generalized | Generalised Anxiety Disorder | Anxiety Disorder; Mixed With Depression (Mild) | Anxiety Disorder GeneralizedUnited Kingdom
-
University of Southern CaliforniaCompletedAnxiety | Depression, Anxiety | Depression Mild | Attention Concentration DifficultyUnited States
-
NeuroGlove LLCRecruitingDepression | Anxiety | Anxiety Depression | Depression, AnxietyUnited States
-
University of Wisconsin, MadisonNot yet recruiting
-
Northern Jiangsu People's HospitalRecruitingDepression, AnxietyChina
-
University of South FloridaNational Institute of Mental Health (NIMH)RecruitingDepression | Anxiety | Depression/AnxietyUnited States
Clinical Trials on Whole Selves
-
Liverpool John Moores UniversityCompletedDiabetes Mellitus, Type 2United Kingdom
-
Stuart FiskGilead Sciences; University of Pittsburgh; Allegheny Singer Research Institute... and other collaboratorsTerminatedHIV PreventionUnited States
-
Xiaofan ZhuAvailableFanconi Anemia | Autosomal or Sex Linked Recessive Genetic Disease | Bone Marrow Hematopoiesis Failure, Multiple Congenital Abnormalities, and Susceptibility to Neoplastic Diseases. | Hematopoiesis Maintainance.China
-
University of ManitobaPulse CanadaCompleted
-
Children's Hospital of Fudan UniversityRecruitingDiarrhea, Infantile | EnteropathyChina
-
Thomas Jefferson UniversityRecruitingGenetic Disorders | Nonimmune Fetal Hydrops | Nonimmune Hydrops in NeonateUnited States
-
USDA Beltsville Human Nutrition Research CenterCompleted
-
Gazi UniversityGulhane Training and Research HospitalRecruitingArthropathy of Knee | Whole-body Vibration | Swelling/ EdemaTurkey
-
Federal University of Health Science of Porto AlegreCompletedChronic Obstructive Pulmonary DiseaseBrazil